Patents by Inventor Caihong Huang

Caihong Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148818
    Abstract: The invention relates to an ophthalmic pharmaceutical composition and its preparation methods and applications, wherein the pharmaceutical composition comprises of L-Alanyl-L-Glutamine suspended or dissolved in an isoosmotic solution suitable for human eyes, and has the advantages causing minimal irritation, with high stability and a good safety profile, and which can be used for relieving dry eye disease (DED) symptoms and/or improving and/or treating DED.
    Type: Application
    Filed: November 22, 2023
    Publication date: May 9, 2024
    Inventors: Zuguo Liu, Yufen Zhao, Caihong Huang, Yang Wu, Guo Tang, Yan Liu, Pengxiang Xu
  • Publication number: 20210293833
    Abstract: A method for screening adulteration of fibrate anti-hyperlipidemia chemicals in tea by combined method of high performance thin layer chromatography (HPTLC) and bioluminescence, which belongs to the field of food inspection. The method includes: firstly, formulating standard solutions of bezafibrate and ciprofibrate, and preparing a tea sample; pre-washing a thin-layer plate and then performing HPTLC spotting; performing HPTLC separation to move original mixed target objects mixed originally onto different positions of the thin-layer plate according to different molecular structures, so as to form a physical isolation; and subsequently, simultaneous detection of multiple targets in the tea sample could be realized conveniently through luminous bacteria coupled with the thin-layer plate by an immersed manner.
    Type: Application
    Filed: May 24, 2019
    Publication date: September 23, 2021
    Applicant: Jiangnan University
    Inventors: Yisheng CHEN, Caihong HUANG, Lanping SHU, Xueming XU, Zhengyu JIN, Jie LONG, Yaoqi TIAN, Yuxiang BAI, Na YANG, Yamei JIN
  • Publication number: 20210030833
    Abstract: The invention relates to an ophthalmic pharmaceutical composition and its preparation methods and applications, wherein the pharmaceutical composition comprises of L-Alanyl-L-Glutamine suspended or dissolved in an isoosmotic solution suitable for human eyes, and has the advantages causing minimal irritation, with high stability and a good safety profile, and which can be used for relieving dry eye disease (DED) symptoms and/or improving and/or treating DED.
    Type: Application
    Filed: January 22, 2019
    Publication date: February 4, 2021
    Inventors: Zuguo Liu, Yufen Zhao, Caihong Huang, Yang Wu, Guo Tang, Yan Liu, Pengxiang XU